With the new Super-deduction tax relief, is there a better  
investment than a Maestro2?  
 
 
One Scan 
One Report 
One Instrument 
 
Maestro2 provides OCT scans, true colour* fundus imaging and the  
Hood report for Glaucoma. 
Now with OCTA. 
 
Maestro2 offers RTC 
Remote Tablet Control** 
 
With Super-deduction tax relief, there's never been a better time to invest. 
 
*True, full colour fundus image simultaneously captured with white light, 24-bit color. 
**Applicable distance is subject to the device's communication performance and the communication environment.  

Maximising the benefits of Super-deduction tax relief... 

The following business benefits will be applicable to Limited companies: 
 
Up to 130% capital allowance in the first year for business investing in qualifying assets. 
Reduced tax liability - Full tax relief is received in the year assets are purchased, not over several years. 
Faster tax relief for qualifying investments up to £1 million. 
 
Return on Investment 
Topcon has developed an ROI calculator and will work with you to provide a bespoke and highly accurate guide to the efficiencies that can be achieved from Maestro2. 
 
Based on a 5 day test week 
2 patients a day 
£25 charge per scan 
 
 
Just 1 patient per day to break even! 
Subject to status. 
Terms & conditions apply. 

   Next Steps... Please contact your Topcon representative to find out more about Maestro2. 

 
 
Call: 01635 551 120 
Email: medical@topcon.co.uk 
Visit: www.topcon-medical.co.uk 
Funding Provided By: 
Subject to credit approval 
Applies to non-regulated finance only 
Exclusive to Performance Finance 
This is only available on the 5-year lease of HP option. 
Registered in England Registration No: 4725729 Performance Finance Limited is authorised and regulated by the Financial Conduct Authority firm reference number 689894. 
We are a credit broker and a consumer credit lender, please be aware that business and commercial finance falls outside the scope of regulation. 
Our site uses cookies. For more information, see our cookie policy. Accept cookies and close
Reject cookies Manage settings